About Leukemia Texas

Leukemia Texas, a Platinum Rated, award-winning non-profit organization is dedicated to improving the lives of those with leukemia through the funding of research and patient aid in Texas. Celebrating over 50 years as an independent 501c3 nonprofit corporation, Leukemia Texas is not affiliated with any other leukemia, health, or nonprofit organization and does not receive government funding. The majority of funds are raised through annual special events as well as individual contributors and corporate sponsors. We are the only organization of its kind in Texas, where 100% of our funds raised in Texas, stay in Texas!

Through the Patient Aid program, Leukemia Texas provides direct financial assistance to leukemia patients in Texas who need help paying for prescribed treatment expenses left uncovered by insurance. Leukemia Texas Patient Aid currently serves hundreds of individuals ranging in age from 1 year to over 90 years old. We currently award up to $1,000 per year per patient in the program. Leukemia Texas does not discriminate based on age, race, gender, or creed.

Funding leukemia research is also a pillar of Leukemia Texas’ lifesaving mission. Through the Research Program, Leukemia Texas is committed to supporting translational science and advancing research careers in Texas. Leukemia Texas-supported findings are often translated into guidelines that help providers improve care for their patients, which may ultimately lead to a cure for leukemia.

The Leukemia Texas Research Program has granted millions of dollars towards studies conducted at Cook Children’s Medical Center, UNT Health Science Center, Baylor Research Institute, UT Southwestern Medical Center, The University of Texas Health Science Center at San Antonio, The University of Texas M.D. Anderson Cancer Center, Center For Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, Houston Methodist and others. This research has been internationally recognized with results published in the Journal of the American Medical Association, Proceedings of the National Academy of Science, The Lancet, Journal of Clinical Oncology, Future Science, Tissue Antigens, Biology of Blood and Marrow Transplantation and Hematology/Oncology Clinics of North America. These findings have also been presented at the National Marrow Donor Program Conference, American Society of Hematology Annual Conference, Annual HLA Advanced Technical Workshop, and the Annual Conference on the Gene Therapy of Cancer. Expert recommendations on LTX Research Grant finalists are made by an independent, volunteer Medical Advisory Committee of prominent and qualified MD’s and PhD’s outside of Texas, across the country with expertise and passion in leukemia research.

In addition to awarding millions of dollars to leukemia patients and scientific researchers, Leukemia Texas is also known for its spectacular fundraising events that include, the Beat Leukemia Ball, Swing Fore Leukemia, Strikeout Pediatric Leukemia and countless fundraisers put together by state-wide corporations, schools, and individuals.